Technology Focus: Giving Patients a Lift
OptiLift uses proprietary Dynamic Muscle Stimulation technology to restore muscle tone to the face to address lower lid laxity and impaired blinking.
Clinical Scorecard: Technology Focus: Giving Patients a Lift
At a Glance
Category Detail
Condition Dry Eye Disease (DED) Key Mechanisms Dynamic Muscle Stimulation (DMSt) technology and radiofrequency for muscle tone restoration and collagen enhancement. Target Population Patients older than age 30, particularly those with eyelid laxity and dry eye symptoms. Care Setting In-office treatment with a focus on noninvasive procedures.
Key Highlights
OptiLift addresses eyelid laxity to improve tear break-up time and overall eye comfort. DMSt technology enhances blink mechanics and provides aesthetic improvements. Patients report increased comfort, brighter appearance, and improved visual clarity. The device is contraindicated for patients with implanted electronic devices. In-office treatments can enhance patient satisfaction and practice growth. Guideline-Based Recommendations
Diagnosis
Assess eyelid laxity and its impact on dry eye symptoms. Management
Incorporate OptiLift as part of the DED treatment algorithm for patients with eyelid laxity. Monitoring & Follow-up
Evaluate patient satisfaction and symptom relief post-treatment. Risks
Contraindicated in patients with pacemakers, defibrillators, or metal implants near treatment area. Patient & Prescribing Data
Patients experiencing dry eye symptoms associated with eyelid laxity, particularly those over 30.
OptiLift provides symptomatic relief and aesthetic benefits, enhancing patient confidence.
Clinical Best Practices
Create a calming treatment environment to enhance patient experience. Educate patients on the benefits of addressing eyelid laxity in DED management. Encourage patient feedback to improve treatment protocols. References
